Z-D-Arg-Gly-Arg-pNA 2HCl
Need Assistance?
  • US & Canada:
    +
  • UK: +

Z-D-Arg-Gly-Arg-pNA 2HCl

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Z-D-Arg-Gly-Arg-pNA 2HCl is a chromogenic substrate for determining factor Xa.

Category
Others
Catalog number
BAT-015098
CAS number
113711-77-6
Molecular Formula
C28H39N11O7.2HCl
Molecular Weight
714.61
Z-D-Arg-Gly-Arg-pNA 2HCl
IUPAC Name
benzyl N-[(2R)-5-(diaminomethylideneamino)-1-[[2-[[(2S)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]carbamate;dihydrochloride
Synonyms
L-Argininamide, N2-[(Phenylmethoxy)carbonyl]-D-arginylglycyl-N-(4-nitrophenyl)-, Dihydrochloride; N2-[(Benzyloxy)carbonyl]-D-arginylglycyl-N-(4-nitrophenyl)-L-argininamide hydrochloride (1:2); Z-RGR-pNA; Benzyl-D-Arg-Gly-Arg-pNA dihydrochloride; Benzyl-D-Arg-Gly-Arg-p-nitroanilide dihydrochloride; Factor Xa Chromogenic Substrate dihydrochloride; S-2765 dihydrochloride
Related CAS
196605-69-3 (free base)
Appearance
White to Slightly Yellow Powder
Purity
95%
Sequence
Cbz-D-Arg-Gly-Arg-pNA.2HCl
Storage
Store at -20°C
Solubility
Soluble in DMSO (Slightly), Methanol, Water (Slightly)
InChI
InChI=1S/C28H39N11O7.2ClH/c29-26(30)33-14-4-8-21(38-28(43)46-17-18-6-2-1-3-7-18)24(41)35-16-23(40)37-22(9-5-15-34-27(31)32)25(42)36-19-10-12-20(13-11-19)39(44)45;;/h1-3,6-7,10-13,21-22H,4-5,8-9,14-17H2,(H,35,41)(H,36,42)(H,37,40)(H,38,43)(H4,29,30,33)(H4,31,32,34);2*1H/t21-,22+;;/m1../s1
InChI Key
SSYLORYZHRLKBF-ZZYOSWMOSA-N
Canonical SMILES
C1=CC=C(C=C1)COC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-].Cl.Cl
1. Locating the rate-determining step(s) for three-step hydrolase-catalyzed reactions with DYNAFIT
Daoning Zhang, Ildiko M Kovach, John Paul Sheehy Biochim Biophys Acta. 2008 May;1784(5):827-33. doi: 10.1016/j.bbapap.2008.02.004. Epub 2008 Mar 10.
Hydrolytic reactions of oligopeptide 4-nitroanilides catalyzed by human-alpha-thrombin, human activated protein C and human factor Xa were studied at pH 8.0-8.4 and 25.0+/-0.1 degrees C by the progress curve method and individual rate constants were calculated mostly within 10% internal error using DYNAFITV. A systematic strategy has been developed for fitting a three-step consecutive mechanism to eighteen hundred to six thousand time-course data points polled from two to four independent kinetic experiments. Enzyme and substrate concentrations were also calculated. Individual rate constants well reproduce published values obtained under comparable conditions and the Michaelis-Menten kinetic parameters calculated from these elementary rate constants are also within reasonable limits of published values. For comparison, the integrated Michaelis-Menten equation was also fitted to data from twelve sets. Both the k(cat) and k(cat)/K(m) values are within 15% agreement with those calculated using the elementary rate constants obtained with DYNAFITV. Rate constants for the second and third consecutive steps are within 3-4 fold indicating that both determine the overall rate. The Factor Xa-catalyzed hydrolysis of N-alpha-Z-D-Arg-Gly-Arg-pNA.2HCl at pH 8.4 in a series of buffers containing increasing fractions of deuterium at 25.0+/-0.1 degrees C shows a very strong dependence of k(3) and a moderate dependence of k(2) on D content in the buffer: the fractionation factors are: 0.49+/-0.03 for K(1,) 0.70+/-0.05 for k(2), and (0.32+/-0.03)(2) for k(3).
2. Isolation of anticoagulant from the venom of tick, Boophilus calcaratus, from Uzbekistan
Toshio Motoyashiki, Anthony T Tu, Djaloliddin A Azimov, Kazakov Ibragim Thromb Res. 2003 Jun 1;110(4):235-41. doi: 10.1016/s0049-3848(03)00409-2.
Boophilus calcaratus is a tick found in Central Asia and a common parasite to domestic animals. Venom from this tick was fractionated by two-step column chromatography, Sephadex G-75, and DEAE-Sephadex A-25. The homogeneity of the anticoagulant was examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The purified component is named calcaratin and has a molecular weight of 14,500. The effect of the purified anticoagulant component (calcaratin) on various sites of the blood coagulation cascade scheme was examined and compared with crude venom. The chromogenic substrates S-2238 (H-D-Phe-Pip-Arg-pNA 2HCl) for thrombin and S-2765 (N-alpha-Z-D-Arg-Gly-Arg-pNA 2HCl) for factor Xa were also investigated. Activated partial clotting times were all prolonged, suggesting the anticoagulation nature of the purified component and crude venom. Prolongation of fibrinogen clotting time (FCT) is highly suggestive of the antithrombin property of the purified component and its original venom.
3. Deuterium solvent isotope effect and proton-inventory studies of factor Xa-catalyzed reactions
Daoning Zhang, Ildiko M Kovach Biochemistry. 2006 Nov 28;45(47):14175-82. doi: 10.1021/bi061218m.
Kinetic solvent isotope effects (KSIEs) for the factor Xa (FXa)-catalyzed activation of prothrombin in the presence and absence of factor Va (FVa) and 5.0 x 10(-5) M phospholipid vesicles are slightly inverse, 0.82-0.93, when substrate concentrations are at 0.2 Km. This is consistent with the rate-determining association of the enzyme-prothrombin assembly, rather than the rate-limiting chemical transformation. FVa is known to effect a major conformational change to expose the first scissile bond in prothrombin, which is the likely event triggering a major solvent rearrangement. At prothrombin concentrations > 5 Km, the KSIE is 1.6 +/- 0.3, when FXa is in a 1:1 ratio with FVa but becomes increasingly inverse, 0.30 +/- 0.05 and 0.19 +/- 0.04, when FXa/FVa is 1:4, with an increasing FXa and substrate concentration. The rate-determining step changes with the conditions, but the chemical step is not limiting under any circumstance. This corroborates the proposed predominance of the meizothrombin pathway when FXa is well-saturated with the prothrombin complex. In contrast, the FXa-catalyzed hydrolysis of N-alpha-Z-D-Arg-Gly-Arg-pNA.2HCl (S-2765) and H-D-Ile-L-Pro-L-Arg-pNA.HCl (S-2288) is most consistent with two-proton bridges forming at the transition state between Ser195 OgammaH and His57 N(epsilon)2 and His57 Ndelta1 and Asp102 COObeta- at the active site, with transition-state fractionation factors of phi1 = phi2 = 0.57 +/- 0.07 and phiS = 0.78 +/- 0.16 for solvent rearrangement for S-2765 and phi1 = phi2 = 0.674 +/- 0.001 for S-2288 under enzyme saturation with the substrate at pH 8.40 and 25.0 +/- 0.1 degrees C. The rate-determining step(s) in these reactions is most likely the cleavage of the C-N bond and departure of the leaving group.
Online Inquiry
Verification code
Inquiry Basket